Macarena Chocan Vera

Macarena Chocan Vera

Auto-generated profile, based on publicly available information

Macarena Chocan Vera

Institut de Recherche Expérimentale et Clinique, Molecular Imaging Radiotherapy and Oncology (MIRO), UCLouvain, Avenue Hippocrate 55/B1.55.01, Brussels, 1200, BELGIUM

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Acta Oncologica
Verified
Journal Article
Open access
PDF file
MCMacarena S. Chocan
Macarena S. Chocan
SWSophie Wuyckens
Sophie Wuyckens
DDDamien Dasnoy
Damien Dasnoy
DPDario Di Perri
Dario Di Perri
EVElena Borderias Villarruel
Elena Borderias Villarruel
ESEdmond Sterpin
Edmond Sterpin
Background and purpose: Intensity Modulated Proton Therapy (IMPT) faces challenges in lung cancer treatment, like maintaining plan robustness for moving tumors against setup, range errors, and interplay effects. Proton Arc Therapy (PAT) is an alternative to maintain target coverage, potentially improving organ at risk (OAR) sparing, reducing beam delivery time (BDT), and enhancing patient experience. We aim to perform a systematic plan comparison study between IMPT and energy layer (EL) and spot assignment algorithm – Proton Arc Therapy (ELSA-PAT) to assess its potential for lung cancer treatment. Material and methods: A total of 14 Lung ELSA-PAT plans were compared retrospectively with IMPT plans. 4D worst-case minimax robust optimization was performed, including 84 scenarios (3%, 3 mm). Dosimetry assessment included target (clinical tumor volume [CTV]) and important OARs, on nominal and worst-case scenarios. Most relevant normal tissue complication probabilities (NTCP), target coverage robustness against interplay effect, and BDT were evaluated. Results: CTV D95% and D98% showed no significant difference in comparison. PAT demonstrated better conformality by 66% (p = 0.00012) but delivered a higher heart mean dose (HMD, 23%). There was a 2% increase in NTCP 2-year mortality risk with PAT. Total BDT was comparable among techniques. IMPT was more robust than PAT against interplay effect, considering both D1% (1.0 ± 0.8 Gy vs 1.1 ± 1.4 Gy) and D98% bandwidths (0.9 ± 0.9 Gy vs 1.1 ± 1.3 Gy). Interpretation: Both techniques provide a similar level of dose coverage to the target volume. Although PAT improved dose conformality, higher HMD translated into increased heart toxicity, presumably due to chosen planning methodology and OAR proximity to target. Increased ELs and spots raised PAT BDT, although it could improve daily treatment workflow.

24 September 2025 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
MVMacarena Chocan Vera
Macarena Chocan Vera
AWAnne-Catherine Wéra
Anne-Catherine Wéra
HOHamdiye Ozan
Hamdiye Ozan
EEErik Engwall
Erik Engwall
VWViktor Wase
Viktor Wase
ESEdmond Sterpin
Edmond Sterpin
Particle Arc Therapy (PAT) is considered a promising technique to improve conformity and reduce toxicities. Robustly optimized PAT plans were evaluated versus Intensity Modulated Proton Therapy (IMPT) for oesophageal cancer in 17 patients. Impact of motion, setup and range uncertainties on target coverage, plan quality and Organs At Risk (OAR) doses were assessed. PAT (two 80°–200°arcs) reduced OAR doses (spinal canal D0.05cm3: 5.12 Gy (12.8%), lungs and heart Dmean: 0.39 Gy (8.8%) and 0.83 Gy (10.5%)) while maintaining robustness. Similar toxicities were observed, but delivery time was doubled for PAT, indicating that further development is needed.

31 January 2025 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
PHPascal Herbst
Pascal Herbst
CDCamille Draguet
Camille Draguet
AMAna Maria Barragan Montero
Ana Maria Barragan Montero
EVElena Borderías Villarroel
Elena Borderías Villarroel
MVMacarena Chocan Vera
Macarena Chocan Vera
ESEdmond Sterpin
Edmond Sterpin
Proton therapy for oesophageal cancer is administered over multiple fractions, based on a single pre-treatment image. However, anatomical changes can lead to the deterioration of the treatment plan, necessitating manual replanning. To keep this within limits, increased residual margins are employed. This study aimed to evaluate the proposed automated Online Adaptive Proton Therapy (OAPT) strategies on their capability to reduce the need for manual replanning, while also exploring the possibility of margin reduction. Two automated OAPT methods were examined: Automated Dose Restoration (ADR) and Automated Full Adaptation (AFA). ADR makes use of dose restoration, restoring the original dose map based on the patient's altered anatomy. AFA adapts the contours used for plan optimization by applying a deformation field, not only correcting for density changes, but also for the relative location of organs. A comparative analysis of OAPT strategies, evaluating D 98% tumour coverage on 17 patients, was conducted. The nominal results of non-adapted plans with 7 mm residual margins required manual replanning for 18% of the patients. ADR reduced this to 6%, while AFA eliminated the need for manual replanning. With 2 mm margins, 47% of cases required manual replanning. ADR reduced this to 18%, and AFA further reduced it to 11%. The proposed OAPT strategies offered a marked improvement compared to a non-adaptive approach. ADR and AFA significantly reduced the necessity for manual replanning and facilitated the reduction of residual margins, enhancing dose conformity and reducing treatment toxicity.

5 March 2025 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
BRBenjamin Roberfroid
Benjamin Roberfroid
MVMacarena S Chocan Vera
Macarena S Chocan Vera
CDCamille Draguet
Camille Draguet
JLJohn A Lee
John A Lee
AMAna Maria Barragan Montero
Ana Maria Barragan Montero
ESEdmond Sterpin
Edmond Sterpin
Objective. Achieving FLASH dose rate with pencil beam scanning intensity modulated proton therapy is challenging. However, utilizing a single energy layer with a ridge filter (RF) can maintain dose rate and conformality. Yet, changes in patient anatomy over the treatment course can render the RF obsolete. Unfortunately, creating a new RF is time-consuming, thus, incompatible with online adaptation. To address this, we propose to re-optimize the spot weights while keeping the same initial RF. Approach. Data from six head and neck cancer patients with a repeated computed tomography (CT2) were used. FLASH treatment plans were generated with three methods on CT2: ‘full-adaptation’ (FA), optimized from scratch with a new RF; ‘spot-adaptation only’ (SAO), re-using initial RF but adjusting plan spot weights; and ‘no adaptation’ (NoA) where the dose from initial plans on initial CT (CT1) was recomputed on CT2. The prescribed dose per fraction was 9 Gy. Different beam angles were tested for each CT2 (1 beam per fraction). The FA, SAO and NoA plans were then compared on CT2. Main results. Fractions with SAO showed a median decrease of 0.05 Gy for D98% and a median increase of 0.03 Gy for D2% of CTV when compared to their homologous FA plans on nominal case. Median conformity number decreased by 0.03. Median max dose to spinal cord increased by 0.09 Gy. The largest median increase in mean dose to organs was 0.03 Gy to the mandible. The largest observed median difference in organs receiving a minimal dose rate of 40 Gy s−1 was 0.5% for the mandible. Up to 16 of the 20 evaluated SAO fractions were thus deemed clinically acceptable, with up to 8 NoA plans already acceptable before adaptation. Significance. Proposed SAO workflow showed that for most of our evaluated plans, daily reprinting of RF was not necessary.

25 September 2024 in arXiv
Verified
Preprint
Open access
PDF file
MCMacarena S. Chocan
Macarena S. Chocan
SWSophie Wuyckens
Sophie Wuyckens
DDDamien Dasnoy
Damien Dasnoy
DPDario Di Perri
Dario Di Perri
EVElena Borderias Villarruel
Elena Borderias Villarruel
ESEdmond Sterpin
Edmond Sterpin
Background and purpose: IMPT faces challenges in lung cancer treatment, like maintaining plan robustness for moving tumors against setup, range errors, and interplay effects. Proton Arc Therapy (PAT) is an alternative to maintain target coverage, potentially improving organ at risk (OAR) sparing, reducing beam delivery time (BDT), and enhancing patient experience. We aim to perform a systematic plan comparison study between IMPT and ELSA-PAT to assess its potential for lung cancer treatment. Material and Methods: 14 Lung ELSA-PAT plans were compared retrospectively with IMPT plans. 4D worst-case minimax robust optimization was performed, including 84 scenarios (3%,3 mm). Dosimetry assessment included target (CTV) and important OARs, on nominal and worst-case scenarios. Most relevant normal tissue complication probabilities (NTCP), target coverage robustness against interplay effect and beam delivery time (BDT) were evaluated. Results: CTV D95% and D98% showed no significant difference in comparison. PAT demonstrated better conformality by 66% (p = 0.00012) but delivered a higher heart mean dose (HMD,23%). There was a 2% increase in NTCP 2-year mortality risk with PAT. Total BDT was comparable among techniques. IMPT was more robust than PAT against interplay effect, considering both D1% (1,0 $\pm$ 0.8 Gy vs 1.1 $\pm$ 1.4 Gy) and D98% bandwidths (0.9$\pm$0.9 Gy vs 1.1 $\pm$ 1.3 Gy). Interpretation: both techniques provide a similar level of dose coverage to the target volume. Although PAT improved dose conformality, higher HMD translated into increased heart toxicity, presumably due to chosen planning methodology and OAR proximity to target. Increased energy layers and spots raised PAT beam delivery time, although it could improve daily treatment workflow.